Inventor
FLANAGAN MARK E
US35 patents
⚠️ This page may combine multiple inventors who share the name “FLANAGAN MARK E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
32 patentsUS6627754B2Sep 30, 2003
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER103 citations99
US6962993B2Nov 8, 2005
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER68 citations98
US6635762B1Oct 21, 2003
Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
PFIZER151 citations98
US10208019B2Feb 19, 2019
GLP-1 receptor agonists and uses thereof
PFIZER50 citations97
US7091208B2Aug 15, 2006
Pyrrolo[2,3-D]pyrimidine compounds
PFIZER34 citations96
US6956041B2Oct 18, 2005
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER37 citations96
US6610847B2Aug 26, 2003
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER48 citations95
US11512070B2Nov 29, 2022
GLP-1 receptor agonists and uses thereof
PFIZER11 citations93
US10851081B2Dec 1, 2020
GLP-1 receptor agonists and uses thereof
PFIZER12 citations93
US10669259B2Jun 2, 2020
GLP-1 receptor agonists and uses thereof
PFIZER13 citations93
USRE41783ESep 28, 2010
Pyrrolo[2,3-D]pyrimidine compounds
PFIZER25 citations92
US7687507B2Mar 30, 2010
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER19 citations92
US7601727B2Oct 13, 2009
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER17 citations92
US7569569B2Aug 4, 2009
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER24 citations92
US7301023B2Nov 27, 2007
Chiral salt resolution
PFIZER31 citations92
US7265221B2Sep 4, 2007
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER15 citations92
US7192963B2Mar 20, 2007
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER23 citations92
US6965027B2Nov 15, 2005
Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate
PFIZER38 citations92
US6890929B2May 10, 2005
Pyrrolo [2,3-D] pyrimidine compounds
PFIZER42 citations92
US6696567B2Feb 24, 2004
Pyrrolo[2,3-d]pyrimidine compounds
PFIZER35 citations92
US7432370B2Oct 7, 2008
Chiral salt resolution
PFIZER19 citations89
US10934279B2Mar 2, 2021
GLP-1 receptor agonists and uses thereof
PFIZER9 citations85
US10683281B2Jun 16, 2020
GLP-1 receptor agonists and uses thereof
PFIZER8 citations83
US10676465B2Jun 9, 2020
GLP-1 receptor agonists and uses thereof
PFIZER8 citations83
US12378230B2Aug 5, 2025
GLP-1 receptor agonists and uses thereof
PFIZER1 citations74
US7842699B2Nov 30, 2010
Pyrrolo[2,3-D]pyrimidine compounds
PFIZER5 citations74
US11858916B2Jan 2, 2024
GLP-1 receptor agonists and uses thereof
PFIZER2 citations71
US12319669B2Jun 3, 2025
GLP-1 receptor agonists and uses thereof
PFIZER0 citations62
US11802121B2Oct 31, 2023
GLP-1 receptor agonists and uses thereof
PFIZER0 citations62
US7803805B2Sep 28, 2010
Cristalline 3-{(3R,4R)-4 methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt
PFIZER4 citations62
US7462600B2Dec 9, 2008
Macrolides
PFIZER3 citations62
US12331041B2Jun 17, 2025
GLP-1 receptor agonists and uses thereof
PFIZER0 citations61